×
For best experience we recommend to activate Javascript in your browser.
CDSE1 antibody (AA 1-245)
This anti-CDSE1 antibody is a Rabbit Polyclonal antibody detecting CDSE1 in WB, IP, IHC and ICC. Suitable for Human.
Quick Overview for CDSE1 antibody (AA 1-245) (ABIN7614825)
Target
See all CDSE1 Antibodies
CDSE1
(Cold Shock Domain Containing E1, RNA-Binding (CDSE1))
Reactivity
All reactivities for CDSE1 antibodies
Human
Host
All hosts for CDSE1 antibodies
Rabbit
Clonality
All clonalities for CDSE1 antibodies
Polyclonal
Conjugate
All conjugates for CDSE1 antibodies
This CDSE1 antibody is un-conjugated
Application
All applications for CDSE1 antibodies
Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
Product Details anti-CDSE1 Antibody
(hide)
Binding Specificity
All epitopes for CDSE1 antibodies
AA 1-245
Purpose
Cold Shock Domain Containing Protein E1, RNA Binding (CSDE1) Polyclonal Antibody
Sequence
Met1~Val245
Characteristics
The Cold Shock Domain Containing Protein E1, RNA Binding (CSDE1) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CDSE1
(hide)
Target
CDSE1
(Cold Shock Domain Containing E1, RNA-Binding (CDSE1))
Alternative Name
CSDE1
Gene ID
7812
UniProt
O75534
Pathways
SARS-CoV-2 Protein Interactome
Recently viewed
(hide)
Chat with us , powered by LiveChat